Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE.

Ann Fam Med. 2009 May-Jun;7(3):212-22. doi: 10.1370/afm.942.

2.

Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.

Ruffin MT, Gorenflo DW, Woodman B.

J Am Board Fam Pract. 2000 Jan-Feb;13(1):1-10. Review.

PMID:
10682879
3.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
4.

The performance of screening tests for ovarian cancer: results of a systematic review.

Bell R, Petticrew M, Sheldon T.

Br J Obstet Gynaecol. 1998 Nov;105(11):1136-47. Review.

PMID:
9853761
5.

The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.

Gohagan JK, Prorok PC, Greenwald P, Kramer BS.

Rev Recent Clin Trials. 2015;10(3):173-80. Review.

PMID:
26238115
6.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
7.

Screening for ovarian cancer in the general population.

Gentry-Maharaj A, Menon U.

Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):243-56. doi: 10.1016/j.bpobgyn.2011.11.006. Epub 2011 Dec 17. Review.

PMID:
22182415
8.

Ovarian cancer screening.

Alexander-Sefre F, Menon U, Jacobs IJ.

Hosp Med. 2002 Apr;63(4):210-3. Review.

PMID:
11995270
9.
10.

Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis.

Reade CJ, Riva JJ, Busse JW, Goldsmith CH, Elit L.

Gynecol Oncol. 2013 Sep;130(3):674-81. doi: 10.1016/j.ygyno.2013.06.029. Epub 2013 Jun 30. Review.

PMID:
23822892
11.

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.

Gren LH, Lamerato LE, Wright P, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):194-9. Review.

PMID:
26238206
12.

Screening postmenopausal women for ovarian cancer: a systematic review.

Fung MF, Bryson P, Johnston M, Chambers A; Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group.

J Obstet Gynaecol Can. 2004 Aug;26(8):717-28. Review.

PMID:
15307976
13.

Problems with prostate-specific antigen screening: a critical review.

Schmid HP, Prikler L, Semjonow A.

Recent Results Cancer Res. 2003;163:226-31; discussion 264-6. Review.

PMID:
12903857
14.

Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.

Gohagan JK, Broski K, Gren LH, Fouad MN, Higgins D, Lappe K, Ogden S, Shambaugh V, Pinsky PF, O'Brien B, Yurgalevich S, Riley T, Wright P, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):187-93. Review.

PMID:
26435288
15.

Early diagnosis of ovarian carcinoma: is a solution in sight?

Lutz AM, Willmann JK, Drescher CW, Ray P, Cochran FV, Urban N, Gambhir SS.

Radiology. 2011 May;259(2):329-45. doi: 10.1148/radiol.11090563. Review.

PMID:
21502390
16.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

17.

Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial.

Bazzi L, Lamerato LE, Varner J, Shambaugh VL, Cordes JE, Ragard LR, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):200-5. Review.

PMID:
26238207
18.

Building Successful Relationships in the PLCO Cancer Screening Trial.

Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S.

Rev Recent Clin Trials. 2015;10(3):181-6. Review.

PMID:
26238208
19.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):233-7. Review.

PMID:
26238116
20.

Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W Jr, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P.

Rev Recent Clin Trials. 2015;10(3):206-11. Review.

PMID:
26238119
Items per page

Supplemental Content

Write to the Help Desk